RT Journal Article
SR Electronic
T1 Unravelling the joint genetic architecture between psychiatic and insulin-related traits in the general population
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.04.24314905
DO 10.1101/2024.10.04.24314905
A1 Sakic, Barbara
A1 Erdogan, Izel
A1 Fanelli, Giuseppe
A1 Arenella, Martina
A1 Mota, Nina Roth
A1 Bralten, Janita
YR 2024
UL http://medrxiv.org/content/early/2024/10/06/2024.10.04.24314905.abstract
AB Attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD) are heritable disorders that frequently co-occur with insulin resistance (IR)-related conditions. Traditional genetic case-control comparisons are challenged by the extent of heterogeneity and comorbidity within and across these conditions. In this study we step away from univariate analyses to let biology guide us to the potential genetic links between insulin and psychiatry-related traits.We used large-scale population-based genetic studies (N= 17,666-697,734) and applied genomic structural equation modeling to identify the factor structure best representing the joint genetic architecture of symptom scores of ADHD, ASD, and OCD, and five IR-related traits: body mass index (BMI), fasting plasma glucose (FPG), fasting plasma insulin, glycated haemoglobin (HbA1c), and homeostatic model assessment for IR. Subsequently we performed multivariate genome-wide association analyses on the psychiatry-IR related factors to explore genetic associations to unravel its biological basis. Factor analyses indicated that a three-factor model fitted the data best (x2(df=9)=18.79, AIC=56.8, CFI=0.99, SRMR=0.068). One factor included ADHD traits and three IR-related traits (BMI, FPG, HbA1c), while another encompassed OCD traits and HbA1c. The last factor included solely IR-related traits. Gene-wide analyses revealed 57 genes significantly associated with the ADHD-IR factor (p< 2.961e-06) and one gene, MTNR1B (p=3.44e-07), with the OCD/OCS-IR factor. Gene-set analyses found associations with neurodevelopmental pathways.Our findings suggest a shared genetic liability between psychiatric symptoms and IR-related traits in the general population, offering new perspectives on the molecular genetics underlying the overlap between psychiatric and IR-related somatic conditions as well as biologically informed clustering within psychiatry.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis publication is part of the project No labels needed: understanding psychiatric disorders based on genetic traits (with project number 09150161910091) of the research program Veni, which is partly financed by the Dutch Research Council (NWO) Health Research and Development (ZonMW). This project has received funding from the European Union Horizon 2020 research and innovation program under grant agreement No. 847879 (PRIME, Prevention and Remediation of Insulin Multimorbidity in Europe). The analyses were carried out on the Dutch national e-infrastructure with the support of SURF Cooperative. Research reported in this publication was supported by the National Institute Of Mental Health of the National Institutes of Health under Award Number R01MH124851.The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funders.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available source data. The publicly available summary statistics of the genome-wide association studies for each phenotype can be located at the following download pages: Attention-deficit/hyperactivity disorder: https://figshare.com/ndownloader/files/40036684 Autism spectrum disorder: https://doi.org/10.6084/m9.figshare.14671989 Obsessive-compulsive disorder: https://doi.org/10.6084/m9.figshare.14672103 Attention-deficit/hyperactivity disorder total symptom score: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068552/bin/NIHMS70115-supplement-Summary_Statistics.gz Sociability: https://doi.org/10.17026/dans-ztj-zga6 Glucose levels two hours after an oral glucose challenge: https://www.ebi.ac.uk/gwas/studies/GCST90002227 Body mass index: https://zenodo.org/records/1251813 https://github.com/lindgrengroup/fatdistnGWAS?tab=readme-ov-file Fasting glucose: https://magicinvestigators.org/downloads/FG_combined_1000G_density_formatted_21-03-29.txt.gz Fasting insulin: https://magicinvestigators.org/downloads/FI_combined_1000G_density_formatted_21-03-29.txt.gz Glycated haemoglobin:https://magicinvestigators.org/downloads/HbA1c_METAL_European.txt.gz Homeostatic model assessment for insulin resistance: https://www.ebi.ac.uk/gwas/studies/GCST005179 Homeostatic model assessment of β-cell function: https://www.ebi.ac.uk/gwas/studies/GCST005180I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are available upon request from the corresponding author.